Publications by authors named "Elif A Oral"

Claim this Profile
P
Precision Medicine: A Circulating Biomarker to Identity People With Pathogenic Variants in the INSR Gene.
Simeon I Taylor, Sayna Bagheri, Elif A Oral, Toni I Pollin

J Clin Endocrinol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted antisense oligonucleotide.
Archna Bajaj, Elif A Oral, Alan Brown, Daniel Gaudet, Veronica J Alexander

Am J Prev Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions.
Ozge Besci, Merve Celik Guler, Maria Cristina Foss-Freitas, Elif Arioglu Oral

Expert Rev Endocrinol Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamin A/C regulates lipid metabolism and inflammation: insights from models of familial partial lipodystrophy 2.
Jessica N Maung, Rebecca L Schill, Akira Nishii, Maria Foss de Freitas, Bonje N Obua, Elif A Oral

J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy.
Rebecca J Brown, Baris Akinci, Matheos Yosef, Helen Phillips, Shokoufeh Khalatbari, Elif A Oral

J Clin Endocrinol Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome.
Donatella Gilio, Ozge Besci, Natália Rossin Guidorizzi, Merve Celik Guler, Ilgin Yildirim Simsir, Elif A Oral

Clin Endocrinol (Oxf)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20-21 May 2025.
Camille Vatier, David Araújo-Vilar, Baris Akinci, Thierry Arnould, Carine Beaupère, Elif A Oral

Ann Endocrinol (Paris)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment.
Donatella Gilio, Maria Foss-Freitas, Elif A Oral

Curr Diab Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response.
Baris Akinci, Nevin Ajluni, Rasimcan Meral, Adam Hugh Neidert, Maria Foss Freitas, Elif Arioglu Oral

J Endocr Soc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program.
Colby L Chase, Marie-Louise Accardo, Veronica Greve, Elizabeth G Ames, Shane C Quinonez, Elif A Oral

J Endocr Soc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of FGF21, soluble TGFBR2, and environmental temperature on metabolic dysfunction in lipodystrophic mice.
Jessica N Maung, Yang Chen, Keegan S Hoose, Rose E Adler, Hadla Hariri, Elif A Oral

JCI Insight· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipodystrophy Syndromes: One Name but Many Diseases Highlighting the Importance of Adipose Tissue in Metabolism.
Maria Foss-Freitas, Donatella Gilio, Elif A Oral

Curr Diab Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world pharmacovigilance assessment and literature review of lymphoma development in lipodystrophy.
Rebecca J Brown, David Araujo-Vilar, Kelly J Walkovich, Alexandru Barbarosie, David A Magee, Elif A Oral

Front Endocrinol (Lausanne)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?
Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, Jeevitha Prativadi, Eric D Frontera, Elif A Oral

Diabetes Care· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series.
Alina Z Mehdi, Lily Deng, Colby L Chase, Maria Cristina Foss-Freitas, Brigid Gregg, Elif A Oral

BMJ Open Diabetes Res Care· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653-659.
Maria C Foss-Freitas, David T Broome, Elif A Oral

Diabetes Care· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY.
David T Broome, Alina Mehdi, Colby Chase, Maria Foss de Freitas, Brigid E Gregg, Elif A Oral

Diabetes Care· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tirzepatide for Lipodystrophy.
Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, Jeevitha Prativadi, Eric D Frontera, Elif A Oral

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipodystrophy Prevalence, "Lipodystrophy-Like Phenotypes," and Diagnostic Challenges.
Baris Akinci, Julia von Schnurbein, David Araujo-Vilar, Martin Wabitsch, Elif A Oral

Diabetes· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic and other morbid complications in congenital generalized lipodystrophy type 4.
Gulcin Akinci, Saif Alyaarubi, Nivedita Patni, Nadia Alhashmi, Azza Al-Shidhani, Elif A Oral

Am J Med Genet A· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity.
Maria C Foss-Freitas, Donatella Gilio, Andre Monteiro da Rocha, Lynn Pais, Melanie C O'Leary, Elif A Oral

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy.
Maria C Foss-Freitas, Salman Imam, Adam Neidert, Anabela Dill Gomes, David T Broome, Elif A Oral

Diabetes Care· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.
Veronica J Alexander, Ewa Karwatowska-Prokopczuk, Thomas A Prohaska, Lu Li, Richard S Geary, Elif A Oral

N Engl J Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor From Taylor et al "Type B Insulin Resistance Syndrome: A Rare Cause of Hypoglycemia".
Simeon I Taylor, Zhinous Shahidzadeh Yazdi, Elif A Oral

JCEM Case Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis